PACIRA BIOSCIENCES, INC. Cost of Revenue
PACIRA BIOSCIENCES, INC. (PCRX) reported Cost of Revenue of $44.16 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Expense Statement
us-gaap:CostOfRevenue · last filed 2026-08-04
- PACIRA BIOSCIENCES, INC. cost of revenue for the quarter ending 2026-06-30 was $44.16M, a 8.07% increase year-over-year.
- PACIRA BIOSCIENCES, INC. cost of revenue for the quarter ending 2026-03-31 was $36.41M, a 6.14% increase year-over-year.
- PACIRA BIOSCIENCES, INC. cost of revenue for the quarter ending 2025-12-31 was $40.30M, a 1.04% increase year-over-year.
- PACIRA BIOSCIENCES, INC. cost of revenue for the quarter ending 2025-09-30 was $34.28M, a 11.80% decline year-over-year.
- PACIRA BIOSCIENCES, INC. cost of revenue for fiscal 2025 was $149.75M, a 12.13% decline from fiscal 2024.
- PACIRA BIOSCIENCES, INC. cost of revenue for fiscal 2024 was $170.43M, a 7.71% decline from fiscal 2023.
- PACIRA BIOSCIENCES, INC. cost of revenue for fiscal 2023 was $184.67M, a 7.34% decline from fiscal 2022.
- PACIRA BIOSCIENCES, INC. cost of revenue for fiscal 2022 was $199.29M, a 42.09% increase from fiscal 2021.
| Period end | Cost of Revenue 3 month | Cost of Revenue 3 month as first filed | Cost of Revenue 6 month | Cost of Revenue 9 month | Cost of Revenue 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $44.16M 10-Q · filed 2026-08-04 | $80.58M 10-Q · filed 2026-08-04 | $120.88M derived: sum of 3 quarters · filed 2026-08-04 | $155.15M derived: sum of 4 quarters · filed 2026-08-04 | |
| 2026-03-31 | $36.41M 10-Q · filed 2026-04-30 | $76.71M derived: sum of 2 quarters · filed 2026-04-30 | $110.99M derived: sum of 3 quarters · filed 2026-04-30 | $151.86M derived: sum of 4 quarters · filed 2026-08-04 | |
| 2025-12-31 | $40.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $74.58M derived: sum of 2 quarters · filed 2026-02-26 | $115.44M derived: sum of 3 quarters · filed 2026-08-04 | $149.75M 10-K · filed 2026-02-26 | |
| 2025-09-30 | $34.28M 10-Q · filed 2025-11-06 | $75.14M derived: sum of 2 quarters · filed 2026-08-04 | $109.45M 10-Q · filed 2025-11-06 | $149.34M derived: sum of 4 quarters · filed 2026-08-04 | |
| 2025-06-30 | $40.87M 10-Q · filed 2026-08-04 | $75.17M 10-Q · filed 2026-08-04 | $115.06M derived: sum of 3 quarters · filed 2026-08-04 | $153.92M derived: sum of 4 quarters · filed 2026-08-04 | |
| 2025-03-31 | $34.31M 10-Q · filed 2026-04-30 | $74.19M derived: sum of 2 quarters · filed 2026-04-30 | $113.06M derived: sum of 3 quarters · filed 2026-04-30 | $157.32M derived: sum of 4 quarters · filed 2026-04-30 | |
| 2024-12-31 | $39.89M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $78.75M derived: sum of 2 quarters · filed 2026-02-26 | $123.01M derived: sum of 3 quarters · filed 2026-02-26 | $170.43M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $38.86M 10-Q · filed 2025-11-06 | $83.13M derived: sum of 2 quarters · filed 2025-11-06 | $130.54M 10-Q · filed 2025-11-06 | $178.23M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-06-30 | $44.26M 10-Q · filed 2025-08-05 | $91.68M 10-Q · filed 2025-08-05 | $139.37M derived: sum of 3 quarters · filed 2026-02-26 | $179.12M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-03-31 | $47.42M 10-Q · filed 2025-05-08 | $95.11M derived: sum of 2 quarters · filed 2026-02-26 | $134.86M derived: sum of 3 quarters · filed 2026-02-26 | $183.06M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2023-12-31 | $47.69M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $87.44M derived: sum of 2 quarters · filed 2026-02-26 | $135.65M derived: sum of 3 quarters · filed 2026-02-26 | $184.67M 10-K · filed 2026-02-26 | |
| 2023-09-30 | $39.75M 10-Q · filed 2024-11-06 | $87.96M derived: sum of 2 quarters · filed 2024-11-06 | $136.98M 10-Q · filed 2024-11-06 | $198.89M derived: sum of 4 quarters · filed 2025-02-27 | |
| 2023-06-30 | $48.21M 10-Q · filed 2024-07-30 | $97.23M 10-Q · filed 2024-07-30 | $159.14M derived: sum of 3 quarters · filed 2025-02-27 | $209.82M derived: sum of 4 quarters · filed 2025-02-27 | |
| 2023-03-31 | $49.02M 10-Q · filed 2024-05-07 | $110.94M derived: sum of 2 quarters · filed 2025-02-27 | $161.61M derived: sum of 3 quarters · filed 2025-02-27 | $212.24M derived: sum of 4 quarters · filed 2025-02-27 | |
| 2022-12-31 | $61.92M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $112.59M derived: sum of 2 quarters · filed 2025-02-27 | $163.22M derived: sum of 3 quarters · filed 2025-02-27 | $199.29M 10-K · filed 2025-02-27 | |
| 2022-09-30 | $50.68M 10-Q · filed 2023-11-02 | $101.31M derived: sum of 2 quarters · filed 2023-11-02 | $137.38M 10-Q · filed 2023-11-02 | $176.39M derived: sum of 4 quarters · filed 2024-02-29 | |
| 2022-06-30 | $50.63M 10-Q · filed 2023-08-02 | $86.70M 10-Q · filed 2023-08-02 | $125.71M derived: sum of 3 quarters · filed 2024-02-29 | $160.36M derived: sum of 4 quarters · filed 2024-02-29 | |
| 2022-03-31 | $36.07M 10-Q · filed 2023-05-03 | $75.08M derived: sum of 2 quarters · filed 2024-02-29 | $109.73M derived: sum of 3 quarters · filed 2024-02-29 | $144.98M derived: sum of 4 quarters · filed 2024-02-29 | |
| 2021-12-31 | $39.01M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $73.66M derived: sum of 2 quarters · filed 2024-02-29 | $108.91M derived: sum of 3 quarters · filed 2024-02-29 | $140.25M 10-K · filed 2024-02-29 | |
| 2021-09-30 | $34.65M 10-Q · filed 2022-11-03 | $69.90M derived: sum of 2 quarters · filed 2022-11-03 | $101.25M 10-Q · filed 2022-11-03 | $136.55M derived: sum of 4 quarters · filed 2022-11-03 | |
| 2021-06-30 | $35.25M 10-Q · filed 2022-08-03 | $66.60M 10-Q · filed 2022-08-03 | $101.89M derived: sum of 3 quarters · filed 2022-08-03 | $131.89M derived: sum of 4 quarters · filed 2022-08-03 | |
| 2021-03-31 | $31.35M 10-Q · filed 2022-05-04 | $66.65M derived: sum of 2 quarters · filed 2022-05-04 | $96.64M derived: sum of 3 quarters · filed 2022-05-04 | $118.94M derived: sum of 4 quarters · filed 2022-05-04 | |
| 2020-12-31 | $35.30M 10-K · filed 2021-03-01 | $65.29M derived: sum of 2 quarters · filed 2021-11-03 | $87.60M derived: sum of 3 quarters · filed 2021-11-03 | $117.33M 10-K · filed 2023-02-28 | |
| 2020-09-30 | $29.99M 10-Q · filed 2021-11-03 | $52.30M derived: sum of 2 quarters · filed 2021-11-03 | $82.03M 10-Q · filed 2021-11-03 | $113.93M derived: sum of 4 quarters · filed 2021-11-03 | |
| 2020-06-30 | $22.30M 10-Q · filed 2021-08-03 | $52.04M 10-Q · filed 2021-08-03 | $83.94M derived: sum of 3 quarters · filed 2021-08-03 | $106.25M derived: sum of 4 quarters · filed 2021-08-03 | |
| 2020-03-31 | $29.73M 10-Q · filed 2021-05-04 | $61.64M derived: sum of 2 quarters · filed 2021-05-04 | $83.94M derived: sum of 3 quarters · filed 2021-05-04 | $109.14M derived: sum of 4 quarters · filed 2021-05-04 | |
| 2019-12-31 | $31.90M 10-K · filed 2021-03-01 | $54.21M derived: sum of 2 quarters · filed 2021-03-01 | $79.41M derived: sum of 3 quarters · filed 2021-03-01 | $106.71M 10-K · filed 2022-02-28 | |
| 2019-09-30 | $22.30M 10-K · filed 2021-03-01 | $47.51M derived: sum of 2 quarters · filed 2021-03-01 | $74.81M 10-Q · filed 2020-10-30 | $98.79M derived: sum of 4 quarters · filed 2021-03-01 | |
| 2019-06-30 | $25.20M 10-K · filed 2021-03-01 | $52.51M 10-Q · filed 2020-08-06 | $76.48M derived: sum of 3 quarters · filed 2021-03-01 | $95.55M derived: sum of 4 quarters · filed 2021-03-01 | |
| 2019-03-31 | $27.30M 10-K · filed 2021-03-01 | $51.28M derived: sum of 2 quarters · filed 2021-03-01 | $70.35M derived: sum of 3 quarters · filed 2021-03-01 | $91.26M derived: sum of 4 quarters · filed 2021-03-01 | |
| 2018-12-31 | $23.98M 10-K · filed 2020-02-21 | $43.04M derived: sum of 2 quarters · filed 2020-02-21 | $63.96M derived: sum of 3 quarters · filed 2020-02-21 | $86.84M 10-K · filed 2021-03-01 | |
| 2018-09-30 | $19.07M 10-K · filed 2020-02-21 | $39.98M derived: sum of 2 quarters · filed 2020-02-21 | $62.87M 10-Q · filed 2019-11-08 | $84.16M derived: sum of 4 quarters · filed 2020-02-21 | |
| 2018-06-30 | $20.92M 10-K · filed 2020-02-21 | $43.80M 10-Q · filed 2019-08-08 | $65.10M derived: sum of 3 quarters · filed 2020-02-21 | $83.32M derived: sum of 4 quarters · filed 2020-02-21 | |
| 2018-03-31 | $22.89M 10-K · filed 2020-02-21 | $44.18M derived: sum of 2 quarters · filed 2020-02-21 | $62.41M derived: sum of 3 quarters · filed 2020-02-21 | $86.22M derived: sum of 4 quarters · filed 2020-02-21 | |
| 2017-12-31 | $21.30M 10-K · filed 2019-02-28 | $39.52M derived: sum of 2 quarters · filed 2019-02-28 | $63.33M derived: sum of 3 quarters · filed 2019-02-28 | $87.92M 10-K · filed 2020-02-21 | |
| 2017-09-30 | $18.23M 10-K · filed 2019-02-28 | $42.04M derived: sum of 2 quarters · filed 2019-02-28 | $66.62M 10-Q · filed 2018-11-01 | $90.24M derived: sum of 4 quarters · filed 2019-02-28 | |
| 2017-06-30 | $23.81M 10-K · filed 2019-02-28 | $48.39M 10-Q · filed 2018-08-02 | $72.01M derived: sum of 3 quarters · filed 2019-02-28 | $115.17M derived: sum of 4 quarters · filed 2019-02-28 | |
| 2017-03-31 | $24.58M 10-K · filed 2019-02-28 | $48.20M derived: sum of 2 quarters · filed 2019-02-28 | $91.35M derived: sum of 3 quarters · filed 2019-02-28 | $114.41M derived: sum of 4 quarters · filed 2019-02-28 | |
| 2016-12-31 | $23.62M 10-K · filed 2018-02-28 | $66.77M derived: sum of 2 quarters · filed 2018-02-28 | $89.83M derived: sum of 3 quarters · filed 2018-02-28 | $110.10M 10-K · filed 2019-02-28 | |
| 2016-09-30 | $43.15M 10-K · filed 2018-02-28 | $66.20M derived: sum of 2 quarters · filed 2018-02-28 | $86.48M 10-Q · filed 2017-11-08 | $105.91M derived: sum of 4 quarters · filed 2018-02-28 | |
| 2016-06-30 | $23.05M 10-K · filed 2018-02-28 | $43.33M 10-Q · filed 2017-08-02 | $62.76M derived: sum of 3 quarters · filed 2018-02-28 | $78.66M derived: sum of 4 quarters · filed 2018-02-28 | |
| 2016-03-31 | $20.28M 10-K · filed 2018-02-28 | $39.70M derived: sum of 2 quarters · filed 2018-02-28 | $55.61M derived: sum of 3 quarters · filed 2018-02-28 | $74.53M derived: sum of 4 quarters · filed 2018-02-28 | |
| 2015-12-31 | $19.43M 10-K · filed 2017-03-01 | $35.33M derived: sum of 2 quarters · filed 2017-03-01 | $54.26M derived: sum of 3 quarters · filed 2017-03-01 | $71.84M 10-K · filed 2018-02-28 | |
| 2015-09-30 | $15.90M 10-K · filed 2017-03-01 | $34.83M derived: sum of 2 quarters · filed 2017-03-01 | $52.41M 10-Q · filed 2016-11-02 | $129.85M derived: sum of 4 quarters · filed 2017-03-01 | |
| 2015-06-30 | $18.93M 10-K · filed 2017-03-01 | $36.51M 10-Q · filed 2016-08-04 | $113.95M derived: sum of 3 quarters · filed 2017-03-01 | $134.34M derived: sum of 4 quarters · filed 2017-03-01 | |
| 2015-03-31 | $17.58M 10-K · filed 2017-03-01 | $95.02M derived: sum of 2 quarters · filed 2017-03-01 | $115.41M derived: sum of 3 quarters · filed 2017-03-01 | $135.37M derived: sum of 4 quarters · filed 2017-03-01 | |
| 2014-12-31 | $77.44M 10-K · filed 2017-03-01 | $18.97M 10-K · filed 2015-02-24 | $97.83M derived: sum of 2 quarters · filed 2017-03-01 | $117.78M derived: sum of 3 quarters · filed 2017-03-01 | $77.44M 10-K · filed 2016-02-25 |
| 2014-09-30 | $20.39M 10-K · filed 2016-02-25 | $40.34M derived: sum of 2 quarters · filed 2016-02-25 | $58.47M 10-Q · filed 2015-10-27 | $76.85M derived: sum of 4 quarters · filed 2016-02-25 | |
| 2014-06-30 | $19.95M 10-K · filed 2016-02-25 | $38.08M 10-Q · filed 2015-07-30 | $56.46M derived: sum of 3 quarters · filed 2016-02-25 | $71.25M derived: sum of 4 quarters · filed 2016-02-25 | |
| 2014-03-31 | $18.13M 10-K · filed 2016-02-25 | $36.50M derived: sum of 2 quarters · filed 2016-02-25 | $51.29M derived: sum of 3 quarters · filed 2016-02-25 | $61.51M derived: sum of 4 quarters · filed 2016-02-25 | |
| 2013-12-31 | $18.38M 10-K · filed 2015-02-24 | $33.17M derived: sum of 2 quarters · filed 2015-02-24 | $43.38M derived: sum of 3 quarters · filed 2015-02-24 | $54.77M 10-K · filed 2016-02-25 | |
| 2013-09-30 | $14.79M 10-K · filed 2015-02-24 | $25.00M derived: sum of 2 quarters · filed 2015-02-24 | $36.40M 10-Q · filed 2014-10-30 | $46.07M derived: sum of 4 quarters · filed 2015-02-24 | |
| 2013-06-30 | $10.21M 10-K · filed 2015-02-24 | $21.61M 10-Q · filed 2014-07-31 | $31.28M derived: sum of 3 quarters · filed 2015-02-24 | $40.56M derived: sum of 4 quarters · filed 2015-02-24 | |
| 2013-03-31 | $11.39M 10-K · filed 2015-02-24 | $21.06M derived: sum of 2 quarters · filed 2015-02-24 | $30.35M derived: sum of 3 quarters · filed 2015-02-24 | $37.03M derived: sum of 4 quarters · filed 2015-02-24 | |
| 2012-12-31 | $9.67M 10-K · filed 2014-02-25 | $18.96M derived: sum of 2 quarters · filed 2014-02-25 | $25.64M derived: sum of 3 quarters · filed 2014-02-25 | $32.14M 10-K · filed 2015-02-24 | |
| 2012-09-30 | $9.29M 10-K · filed 2014-02-25 | $15.97M derived: sum of 2 quarters · filed 2014-02-25 | $22.47M 10-Q · filed 2013-10-31 | $29.07M derived: sum of 4 quarters · filed 2014-02-25 | |
| 2012-06-30 | $6.68M 10-K · filed 2014-02-25 | $13.18M 10-Q · filed 2013-08-06 | $19.78M derived: sum of 3 quarters · filed 2014-02-25 | $23.14M derived: sum of 4 quarters · filed 2014-02-25 | |
| 2012-03-31 | $6.50M 10-K · filed 2014-02-25 | $13.10M derived: sum of 2 quarters · filed 2014-02-25 | $16.45M derived: sum of 3 quarters · filed 2014-02-25 | $19.57M derived: sum of 4 quarters · filed 2014-02-25 | |
| 2011-12-31 | $6.60M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | $9.96M derived: sum of 2 quarters · filed 2014-02-25 | $13.07M derived: sum of 3 quarters · filed 2014-02-25 | $16.74M 10-K · filed 2014-02-25 | |
| 2011-09-30 | $3.36M 10-Q · filed 2012-11-01 | $6.47M derived: sum of 2 quarters · filed 2012-11-01 | $10.14M 10-Q · filed 2012-11-01 | $12.25M derived: sum of 4 quarters · filed 2013-03-07 | |
| 2011-06-30 | $3.12M 10-Q · filed 2012-08-09 | $6.78M 10-Q · filed 2012-08-09 | $8.89M derived: sum of 3 quarters · filed 2013-03-07 | $12.46M derived: sum of 4 quarters · filed 2013-03-07 | |
| 2011-03-31 | $3.67M 10-Q · filed 2012-05-09 | $5.78M derived: sum of 2 quarters · filed 2013-03-07 | $9.35M derived: sum of 3 quarters · filed 2013-03-07 | $12.20M derived: sum of 4 quarters · filed 2013-03-07 | |
| 2010-12-31 | $2.11M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-07 | $5.68M derived: sum of 2 quarters · filed 2013-03-07 | $8.53M derived: sum of 3 quarters · filed 2013-03-07 | $12.28M 10-K · filed 2013-03-07 | |
| 2010-09-30 | $3.57M 10-Q · filed 2011-10-31 | $6.42M derived: sum of 2 quarters · filed 2011-10-31 | $10.17M 10-Q · filed 2011-10-31 | ||
| 2010-06-30 | $2.85M 10-Q · filed 2011-08-11 | $6.59M 10-Q · filed 2011-08-11 | |||
| 2009-12-31 | $12.30M 10-K · filed 2012-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |